jueves, 24 de julio de 2025

DLBCL: FDA Rejects BLA for Second-Line Glofitamab Combo Sharon Worcester July 24, 2025

https://www.medscape.com/viewarticle/dlbcl-fda-rejects-bla-second-line-glofitamab-combo-2025a1000jm4

No hay comentarios:

Publicar un comentario